Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Williamson Robert F III, holds the title of Director at Perspective Therapeutics, Inc..
On 2026-11-18, the insider transacted 15,000 shares.The shares were transacted at a weighted average price of $0.80 per share, resulting in a total market-relevant value of $12K.
Williamson Robert F III (Director) bought $12K of $CATX
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.